United States

Analyst Research Report Snapshot


Cancer-focused diagnostics comapny set for rapid revenue expansion




RedChip Companies, Inc.


23 Aug 2013





Companies referenced:


Available for Immediate Download

Cancer Genetics, Inc. (CGIX) is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. The Company’s tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematologic, urogenital and HPV-associated cancers. CGIX also offers a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. Its state-of-the-art reference lab is focused entirely on maintaining clinical excellence and is both CLIA certified and CAP accredited and has licensure from several states including New York State. CGIX has established strong research collaborations and agreements with major cancer centers such as Mayo Clinic, Memorial Sloan-Kettering, The Cleveland Clinic and the National Cancer Institute. The Company has also established high-profile clinical trial partnerships with Roche and Gilead Sciences through its SelectOne program.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.